Laura J Sherrard1, Gisli G Einarsson2, Elinor Johnston2, Katherine O'Neill2, Leanne McIlreavey2, Stephanie J McGrath3, Deirdre F Gilpin3, Damian G Downey4, Alastair Reid5, Noel G McElvaney6, Richard C Boucher7, Marianne S Muhlebach8, J Stuart Elborn9, Michael M Tunney3. 1. Halo Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK. Electronic address: l.sherrard@qub.ac.uk. 2. Halo Research Group, Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK. 3. Halo Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK. 4. Halo Research Group, Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK; Belfast Health and Social Care Trust, Belfast, UK. 5. Belfast Health and Social Care Trust, Belfast, UK. 6. Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland. 7. Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 8. Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 9. Halo Research Group, Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK; Imperial College and Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK.
Abstract
BACKGROUND: Routine clinical culture detects a subset of the cystic fibrosis (CF) airways microbiota based on culture-independent (molecular) methods. This study aimed to determine how extended sputum culture of viable bacteria changes over time in relation to clinical status and predicts exacerbations. METHODS: Sputa from patients at a baseline stable and up to three subsequent time-points were analysed by extended-quantitative culture; aerobe/anaerobe densities, ecological indexes and community structure were assessed together with clinical outcomes. RESULTS: Eighty patients were prospectively recruited. Sputa were successfully collected and cultured at 199/267 (74.5%) study visits. Eighty-two sputa from 25 patients comprised a complete sample-set for longitudinal analyses. Bacterial density, ecological indexes and clinical outcomes were unchanged in 18 patients with three sequential stable visits. Conversely, in 7 patients who had an exacerbation, total bacterial and aerobe densities differed over four study visits (P < .001) with this difference particularly apparent between the baseline visit and completion of acute antibiotic treatment where a decrease in density was observed. Bacterial communities were more similar within than between patients but stable patients had the least variation in community structure over time. Using logistic regression in a further analysis, baseline features in 37 patients without compared to 15 patients with a subsequent exacerbation showed that clinical measures rather than bacterial density or ecological indexes were independent predictors of an exacerbation. CONCLUSIONS: Greater fluctuation in the viable bacterial community during treatment of an exacerbation than between stable visits was observed. Extended-quantitative culture did not provide prognostic information of a future exacerbation.
BACKGROUND: Routine clinical culture detects a subset of the cystic fibrosis (CF) airways microbiota based on culture-independent (molecular) methods. This study aimed to determine how extended sputum culture of viable bacteria changes over time in relation to clinical status and predicts exacerbations. METHODS: Sputa from patients at a baseline stable and up to three subsequent time-points were analysed by extended-quantitative culture; aerobe/anaerobe densities, ecological indexes and community structure were assessed together with clinical outcomes. RESULTS: Eighty patients were prospectively recruited. Sputa were successfully collected and cultured at 199/267 (74.5%) study visits. Eighty-two sputa from 25 patients comprised a complete sample-set for longitudinal analyses. Bacterial density, ecological indexes and clinical outcomes were unchanged in 18 patients with three sequential stable visits. Conversely, in 7 patients who had an exacerbation, total bacterial and aerobe densities differed over four study visits (P < .001) with this difference particularly apparent between the baseline visit and completion of acute antibiotic treatment where a decrease in density was observed. Bacterial communities were more similar within than between patients but stable patients had the least variation in community structure over time. Using logistic regression in a further analysis, baseline features in 37 patients without compared to 15 patients with a subsequent exacerbation showed that clinical measures rather than bacterial density or ecological indexes were independent predictors of an exacerbation. CONCLUSIONS: Greater fluctuation in the viable bacterial community during treatment of an exacerbation than between stable visits was observed. Extended-quantitative culture did not provide prognostic information of a future exacerbation.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Jiangchao Zhao; Patrick D Schloss; Linda M Kalikin; Lisa A Carmody; Bridget K Foster; Joseph F Petrosino; James D Cavalcoli; Donald R VanDevanter; Susan Murray; Jun Z Li; Vincent B Young; John J LiPuma Journal: Proc Natl Acad Sci U S A Date: 2012-03-26 Impact factor: 11.205
Authors: Vanja Klepac-Ceraj; Katherine P Lemon; Thomas R Martin; Martin Allgaier; Steven W Kembel; Alixandra A Knapp; Stephen Lory; Eoin L Brodie; Susan V Lynch; Brendan J M Bohannan; Jessica L Green; Brian A Maurer; Roberto Kolter Journal: Environ Microbiol Date: 2010-02-23 Impact factor: 5.491
Authors: Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell Journal: J Pediatr Date: 2008-08 Impact factor: 4.406
Authors: Bojana Mirković; Michelle A Murray; Gillian M Lavelle; Kevin Molloy; Ahmed Abdul Azim; Cedric Gunaratnam; Fiona Healy; Dubhfeasa Slattery; Paul McNally; Joe Hatch; Matthew Wolfgang; Michael M Tunney; Marianne S Muhlebach; Rosaleen Devery; Catherine M Greene; Noel G McElvaney Journal: Am J Respir Crit Care Med Date: 2015-12-01 Impact factor: 21.405
Authors: Katherine O'Neill; Judy M Bradley; Elinor Johnston; Stephanie McGrath; Leanne McIlreavey; Stephen Rowan; Alastair Reid; Ian Bradbury; Gisli Einarsson; J Stuart Elborn; Michael M Tunney Journal: PLoS One Date: 2015-05-20 Impact factor: 3.240
Authors: Marieke van Horck; Bjorn Winkens; Geertjan Wesseling; Dillys van Vliet; Kim van de Kant; Sanne Vaassen; Karin de Winter-de Groot; Ilja de Vreede; Quirijn Jöbsis; Edward Dompeling Journal: Sci Rep Date: 2017-09-27 Impact factor: 4.379
Authors: Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan Journal: Respir Res Date: 2021-04-29
Authors: Talia D Valentini; Sarah K Lucas; Kelsey A Binder; Lydia C Cameron; Jason A Motl; Jordan M Dunitz; Ryan C Hunter Journal: Nat Commun Date: 2020-05-08 Impact factor: 14.919
Authors: Claudie Lamoureux; Charles-Antoine Guilloux; Clémence Beauruelle; Stéphanie Gouriou; Sophie Ramel; Anne Dirou; Jean Le Bihan; Krista Revert; Thomas Ropars; Rosyne Lagrafeuille; Sophie Vallet; Rozenn Le Berre; Emmanuel Nowak; Geneviève Héry-Arnaud Journal: Sci Rep Date: 2021-03-25 Impact factor: 4.379
Authors: Gisli G Einarsson; Bart M Vanaudenaerde; Christopher D Spence; Andrew J Lee; Mieke Boon; Geert M Verleden; J Stuart Elborn; Lieven J Dupont; Dirk Van Raemdonck; Deirdre F Gilpin; Robin Vos; Stijn E Verleden; Michael M Tunney Journal: Front Cell Infect Microbiol Date: 2022-03-16 Impact factor: 5.293
Authors: Andrea Hahn; Katrine Whiteson; Trenton J Davis; Joann Phan; Iman Sami; Anastassios C Koumbourlis; Robert J Freishtat; Keith A Crandall; Heather D Bean Journal: Front Cell Infect Microbiol Date: 2020-04-28 Impact factor: 5.293
Authors: Martina Oriano; Laura Zorzetto; Giuseppe Guagliano; Federico Bertoglio; Sebastião van Uden; Livia Visai; Paola Petrini Journal: Front Bioeng Biotechnol Date: 2020-10-20